Month: March 2026

We are proud to be the pioneers of the Nivolumab Access Program in Kenya. Nivolumab is a sophisticated immunotherapy drug that helps the immune system recognize and attack cancer cells.

Unlike traditional "tour-operators," our model is built on permanent alliances with local host organizations to ensure our work is sustainable and ethical.